Home > Insider Trading > Nektar Therapeutics

Nektar Therapeutics (NKTR)

Market is closed

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

News

First
<< Previous
51 - 55

This Metric Says You Are Smart to Buy Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics Inc (NASDAQ:SRPT) was in 19 hedge funds' portfolio at the end of March. SRPT shareholders have witnessed an increase in enthusiasm from smart money in recent months.

Keep Reading →

June 3rd, 2013 - News

Allergan, Inc. (AGN), GlaxoSmithKline plc (ADR) (GSK), and Three 'Cannot Miss' FDA Actions This Week

Earnings season is getting ready to rev into high gear, but earnings are unlikely to be the talk of the sector in the days to come, with three big Food and Drug Administration actions expected in the ...

Keep Reading →

April 14th, 2013 - News

Acorda Therapeutics Inc (ACOR): Insiders Are Dumping, Should You?

Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds' portfolio at the end of the fourth quarter of 2012.

Keep Reading →

April 12th, 2013 - News

Alcoa Inc (AA), F5 Networks, Inc. (FFIV) & More: Three Stocks to Get on Your Watchlist

I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.

Keep Reading →

April 10th, 2013 - News

Do Hedge Funds and Insiders Love Nektar Therapeutics (NKTR)? - Sarepta Therapeutics Inc (SRPT), Acorda Therapeutics Inc (ACOR)

In today’s marketplace, there are many indicators shareholders can use to track their holdings. A duo of the most underrated are hedge fund and insider trading movement.

Keep Reading →

April 5th, 2013 - News